You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0398 Secukinumab sustains individual clinical responses over time in patients with active ankylosing spondylitis: 2-year results from a phase 3 trial, measure 2

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - treatment
THU0398 Secukinumab sustains individual clinical responses over time in patients with active ankylosing spondylitis: 2-year results from a phase 3 trial, measure 2
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Baraliakos X, Schiff M, Pavelka K, et al
THU0398 Secukinumab sustains individual clinical responses over time in patients with active ankylosing spondylitis: 2-year results from a phase 3 trial, measure 2
Annals of the Rheumatic Diseases 2017;76:358.